| ²é¿´: 345 | »Ø¸´: 1 | |||
mxp123ľ³æ (СÓÐÃûÆø)
|
[½»Á÷]
¡¾ÇóÖú¡¿ÇóÖúÓ¢ÎÄÎÄÏ×һƪ¡£Ð»Ð»
|
|
ÌâÄ¿ Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial. лл´ó¼Ò¡£ |
» ²ÂÄãϲ»¶
¸Õ²éʱ¼ä´Á
ÒѾÓÐ16È˻ظ´
µÂ¹ú¿ÆÂ¡´óѧҽѧÖÐÐÄProf. Vogt Ñо¿×éÕÐÆ¸CSC¹«Åɲ©Ê¿Éú¡£
ÒѾÓÐ0È˻ظ´
Ñ»·ÏµÍ³ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ189È˻ظ´
ÇóÅ·ÖÞ£¨Ó¢¹ú£©µÄ·Ãѧ¸Úλ¡ª¡ªÉñ¾ÍËÐÐÐÔ¼²²¡ÄÉÃ×°ÐÏòÒ©Îï·½Ïò
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖú ¶þÑõ»¯îæÄÉÃײÄÁÏ ¸ßÖÊÁ¿×ÛÊöÐÔÍâÎÄÎÄÏ×£¡Ð»Ð»´ó¼Ò
ÒѾÓÐ4È˻ظ´
ÇóÖúÓë»ùÒò¹¤³ÌÓйصÄһƪ´óÔ¼3Ò³µÄÓ¢ÎÄÎÄÏ×
ÒѾÓÐ6È˻ظ´
ÇóÖúÓ¢ÎÄÎÄÏ×һƪ£¬ÓÐÁ´½Ó£¬Ð»Ð»£¡
ÒѾÓÐ1È˻ظ´
ÇóÖú¼¸ÆªÎÄÏ××ÊÁÏ£¬Ð»Ð»
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÇëÎÊҶƬµçµ¼Âʵĸߵͱ仯ÓëÖ²ÎïµÄ¿¹ÐÔÓкιØÏµ£¿µçµ¼ÓÉÓÚÖ²ÎïÊ²Ã´ÌØÐÔÓ
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÔõÑù¸øÎÄÏ××÷Õß·¢Ó¢ÎÄÓʼþ
ÒѾÓÐ3È˻ظ´
ÇóÖú·Ò롾ÌÇ»¯Ã¸¡¿Ó¢ÎÄÎÄÏ×һƪ
ÒѾÓÐ12È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÂÛÎÄ·Ò루Ӣ·ÖУ©
ÒѾÓÐ13È˻ظ´
¡¾ÇóÖú¡¿×¨ÒµÓ¢ÓïÔõôѧϰ
ÒѾÓÐ13È˻ظ´
ËÕ´ò@ҽѧ
½ð³æ (СÓÐÃûÆø)
ºÃÒ½Éú
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1159.2
- É¢½ð: 3
- ºì»¨: 4
- ɳ·¢: 2
- Ìû×Ó: 253
- ÔÚÏß: 38.4Сʱ
- ³æºÅ: 1108247
- ×¢²á: 2010-09-26
- ÐÔ±ð: MM
- רҵ: ¼äÖÊÐԷμ²²¡
mxp123(½ð±Ò+5): 2011-04-26 10:10:04
http://www.nature.com/bjc/journal/v102/n3/abs/6605522a.htmlÎÒÖ»ÄܰïÄãÕÒµ½Õâ¸öÍøÖ·£¬µ«ÊÇ¿´ÔÉùÎÊÊÇÒª¸¶·ÑµÄ |

2Â¥2011-01-29 23:40:47













»Ø¸´´ËÂ¥